Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease.
暂无分享,去创建一个
M. Rubin | F. Demichelis | M. Klagsbrun | L. Insabato | M. Lisanti | M. Moses | D. Di Vizio | M. Hager | M. Morello | R. Adam | M. Freeman | C. D’Souza-Schorey | Hong Wu | N. Bhowmick | D. Mulholland | S. Morley | P. Schow | A. Dudley | Mirja Rotinen | Matteo Morello
[1] R. Vessella,et al. DIAPH3 governs the cellular transition to the amoeboid tumour phenotype , 2012, EMBO molecular medicine.
[2] J. Bono,et al. The changing therapeutic landscape of castration-resistant prostate cancer , 2011, Nature Reviews Clinical Oncology.
[3] G. Camussi,et al. Tumor exploits alternative strategies to achieve vascularization , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] Ryoji Kato,et al. Expected clinical applications of circulating tumor cells in breast cancer. , 2011, World journal of clinical oncology.
[5] N. Beauchemin. The Colorectal Tumor Microenvironment: The Next Decade , 2011, Cancer Microenvironment.
[6] Guido Jenster,et al. Exosomes as biomarker treasure chests for prostate cancer. , 2011, European urology.
[7] P. Kuo,et al. Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis. , 2011, Carcinogenesis.
[8] Ann Pellegrini. Movement , 2011 .
[9] E. Germain,et al. Brain-Derived Neurotrophic Factor and Neurotrophin-4/5 Are Expressed in Breast Cancer and Can Be Targeted to Inhibit Tumor Cell Survival , 2011, Clinical Cancer Research.
[10] J. Rak,et al. Microvesicles as mediators of intercellular communication in cancer—the emerging science of cellular ‘debris’ , 2011, Seminars in Immunopathology.
[11] C. Turner,et al. Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasis , 2011, Molecular biology of the cell.
[12] Francesco Favero,et al. Reduced Expression of the ROCK Inhibitor Rnd3 Is Associated with Increased Invasiveness and Metastatic Potential in Mesenchymal Tumor Cells , 2010, PloS one.
[13] Nancy Guillen,et al. Dynamic instability of the intracellular pressure drives bleb-based motility , 2010, Journal of Cell Science.
[14] R. Adam,et al. An Akt- and Fra-1-dependent pathway mediates platelet-derived growth factor-induced expression of thrombomodulin, a novel regulator of smooth muscle cell migration. , 2010, The American journal of pathology.
[15] Gerhard Christofori,et al. Mechanisms of Motility in Metastasizing Cells , 2010, Molecular Cancer Research.
[16] Z. Werb,et al. Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.
[17] M. Rubin,et al. ERG rearrangement metastasis patterns in locally advanced prostate cancer. , 2010, Urology.
[18] Graca Raposo,et al. ARF6-Regulated Shedding of Tumor Cell-Derived Plasma Membrane Microvesicles , 2009, Current Biology.
[19] R. Premont,et al. Metastasis: Wherefore Arf Thou? , 2009, Current Biology.
[20] F. Sotgia,et al. An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease spread and epithelial Akt activation , 2009, Cell cycle.
[21] M. Rubin,et al. Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. , 2009, Cancer research.
[22] J. Rak,et al. Microvesicles: Messengers and mediators of tumor progression , 2009, Cell cycle.
[23] A. Toker,et al. Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer. , 2009, Cellular signalling.
[24] M. Rubin,et al. Heterogeneous nuclear ribonucleoprotein K is a novel regulator of androgen receptor translation. , 2009, Cancer research.
[25] J. Krijgsveld,et al. Exosomal Secretion of Cytoplasmic Prostate Cancer Xenograft-derived Proteins* , 2009, Molecular & Cellular Proteomics.
[26] Jacopo Meldolesi,et al. Shedding microvesicles: artefacts no more. , 2009, Trends in cell biology.
[27] E. Sahai,et al. Rac Activation and Inactivation Control Plasticity of Tumor Cell Movement , 2008, Cell.
[28] M. Klagsbrun,et al. Calcification of multipotent prostate tumor endothelium. , 2008, Cancer cell.
[29] A. Guha,et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells , 2008, Nature Cell Biology.
[30] M. Loda,et al. Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase , 2008, Cell cycle.
[31] A. Luini,et al. Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation , 2008, Journal of Cell Science.
[32] Thomas Walz,et al. Negative Staining and Image Classification – Powerful Tools in Modern Electron Microscopy , 2004, Biological Procedures Online.
[33] T. Manabe,et al. GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion , 2008, Nature Cell Biology.
[34] Gerhard Christofori,et al. Distinct mechanisms of tumor invasion and metastasis. , 2007, Trends in molecular medicine.
[35] P. Yelick,et al. The pro‐apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1 , 2007, The EMBO journal.
[36] Adam S. Kibel,et al. Integrative molecular concept modeling of prostate cancer progression , 2007 .
[37] M. Loda,et al. Caveolin-1 is required for the upregulation of fatty acid synthase (FASN), a tumor promoter, during prostate cancer progression , 2007, Cancer biology & therapy.
[38] Pierre Roux,et al. Loss of p53 promotes RhoA–ROCK-dependent cell migration and invasion in 3D matrices , 2007, The Journal of cell biology.
[39] Jayoung Kim,et al. Cholesterol sensitivity of endogenous and myristoylated Akt. , 2007, Cancer research.
[40] T. Ratliff. Caveolin-1 Promotes Tumor Progression in an Autochthonous Mouse Model of Prostate Cancer: Genetic Ablation of Cav-1 Delays Advanced Prostate Tumor Development in Tramp Mice , 2006 .
[41] Jason A. Koutcher,et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.
[42] M. Loda,et al. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. , 2005, The Journal of biological chemistry.
[43] M. Becich,et al. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] R. Tibshirani,et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[45] A. Sonnenberg,et al. Stimulation‐Dependent Recycling of Integrin β1 Regulated by ARF6 and Rab11 , 2004, Traffic.
[46] E. Latulippe,et al. Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. , 2004, The American journal of pathology.
[47] P. Nelson,et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. , 2003, Cancer cell.
[48] E. Lander,et al. Gene expression correlates of clinical prostate cancer behavior. , 2002, Cancer cell.
[49] J F Leary,et al. Doublet discrimination in DNA cell-cycle analysis. , 2001, Cytometry.
[50] M. Ittmann,et al. Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. , 2001, Cancer research.
[51] G. Thurston,et al. Mechanics of endothelial cell architecture and vascular permeability. , 2001, Critical reviews in biomedical engineering.
[52] P. Eggli,et al. Protrusive activity, cytoplasmic compartmentalization, and restriction rings in locomoting blebbing Walker carcinosarcoma cells are related to detachment of cortical actin from the plasma membrane. , 1998, Cell motility and the cytoskeleton.
[53] M A Moses,et al. Retinoids modulate endothelial cell production of matrix-degrading proteases and tissue inhibitors of metalloproteinases (TIMP). , 1994, The Journal of biological chemistry.